Cargando…
Antioxidant properties of repaglinide and its protections against cyclosporine A-induced renal tubular injury
OBJECTIVE(S): Repaglinide (RG) is an antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus. It has a good safety and efficacy profile in diabetic patients with complications in renal impairment and is an appropriate treatment choice, even for individuals with more...
Autores principales: | Li, Dao, Li, Jin, Li, Hui, Wu, Qiong, Li, Qi-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010847/ https://www.ncbi.nlm.nih.gov/pubmed/27635199 |
Ejemplares similares
-
Repaglinide-Induced Acute Pancreatitis
por: Udongwo, Ndausung, et al.
Publicado: (2021) -
Prohibitin is associated with antioxidative protection in hypoxia/reoxygenation-induced renal tubular epithelial cell injury
por: Zhou, Tian-Biao, et al.
Publicado: (2013) -
Formulation and Evaluation of Transdermal Patch of Repaglinide
por: Prajapati, Shailesh T., et al.
Publicado: (2011) -
Tubular Kidney Protection by Antioxidants
por: Nasri, Hamid, et al.
Publicado: (2013) -
Crosstalk between Smad and Mitogen-Activated Protein Kinases for the Regulation of Apoptosis in Cyclosporine A- Induced Renal Tubular Injury
por: Iwayama, Hideyuki, et al.
Publicado: (2011)